Host Hotels & Resorts Announces First Quarter 2025 Earnings Call to be Held on May 1, 2025
Newsfilter· 2025-03-14 04:30
BETHESDA, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Host Hotels & Resorts, Inc. (NASDAQ:HST) (the "Company"), the nation's largest lodging real estate investment trust, will report first quarter 2025 financial results on Wednesday, April 30, 2025, after the market close. The Company will hold a conference call to discuss its first quarter 2025 results and business outlook on Thursday, May 1, 2025, at 11:00 a.m. ET. Conference call access information is as follows: Conference Call: | USA/Canada Toll Free Numbe ...
O-I GLASS TO DETAIL STRATEGIC INITIATIVES TO DRIVE LONG-TERM VALUE
GlobeNewswire· 2025-03-14 04:20
PERRYSBURG, Ohio, March 13, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE O-I Glass, Inc. (NYSE: OI), a leading supplier of glass packaging, plans to detail a series of strategic initiatives aimed at enhancing its market position and delivering long-term value to shareholders during its Investors Day presentation at the New York Stock Exchange (NYSE) on March 14th that will begin at 8:30 am. The Power of Glass The Investor Day presentation, titled "The Power of Glass," will feature insights from O-I Glass' ...
Pangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 2024
Prnewswire· 2025-03-14 04:19
NEWPORT, R.I., March 13, 2025 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. ("Pangaea" or the "Company") (NASDAQ: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months and year ended December 31, 2024. FOURTH QUARTER 2024 RESULTS Net income attributable to Pangaea Logistics Solutions Ltd. of $8.4 million, or $0.18 per diluted share Adjusted net income attributable to Pangaea Logistics Solutions Ltd. of $7.6 million, or $0.16 per diluted ...
Titan Machinery Inc. to Report Fiscal Fourth Quarter and Full Year Ended January 31, 2025 Results on Thursday, March 20, 2025
GlobeNewswire· 2025-03-14 04:19
WEST FARGO, N.D., March 13, 2025 (GLOBE NEWSWIRE) -- Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural and construction equipment stores, announced today it will release financial results for the fourth quarter and full year ended January 31, 2025, on Thursday, March 20, 2025, followed by an investor conference call at 7:30 a.m. Central time (8:30 a.m. Eastern time). Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. International c ...
Portman Ridge Finance Corporation Announces Fourth Quarter and Full Year 2024 Financial Results
Newsfilter· 2025-03-14 04:16
Reports Net Investment Income of $2.59 Per Share for Full Year 2024 and Net Asset Value of $19.41 Per Share Continued Share Repurchase Program: Total of 202,357 Shares for an Aggregate Cost of Approximately $3.8 Million Repurchased During Full Year 2024; Accretive to NAV by $0.07 Per Share Announces First Quarter 2025 Regular Quarterly Base Distribution of $0.47 Per Share and Introduces a Quarterly Supplemental Distribution of $0.07 Per Share Merger Agreement with Logan Ridge Aims to Create Meaningful Share ...
Logan Ridge Finance Corporation Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire· 2025-03-14 04:16
Reports Strong Fourth Quarter Results with Net Investment Income of $0.56 Per Share and a Net Asset Value of $32.04 Per Share Declared a Distribution of $0.36 Per Share for the First Quarter of 2025 Subsequent to Quarter End, LRFC Successfully Exited its Equity Investment in GA Communications, Inc., Further Reducing the Company’s Non-Yielding Equity Portfolio Merger Agreement with Portman Ridge Finance Corporation Aims to Create Meaningful Shareholder Value Via Greater Scale, Enhanced Liquidity, and Improve ...
Portman Ridge Finance Corporation Announces Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire· 2025-03-14 04:16
Reports Net Investment Income of $2.59 Per Share for Full Year 2024 and Net Asset Value of $19.41 Per Share Continued Share Repurchase Program: Total of 202,357 Shares for an Aggregate Cost of Approximately $3.8 Million Repurchased During Full Year 2024; Accretive to NAV by $0.07 Per Share Announces First Quarter 2025 Regular Quarterly Base Distribution of $0.47 Per Share and Introduces a Quarterly Supplemental Distribution of $0.07 Per Share Merger Agreement with Logan Ridge Aims to Create Meaningful Share ...
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire· 2025-03-14 04:15
Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today reported financial results for the third quarter fiscal 2025 ended January 31, 2025 and provided a business update. Third Fiscal Quarter 2025 Highlights: During the third quarter of fiscal year 2025 (“Q3 FY2025”) and t ...
Plymouth Industrial REIT Appoints Robert O. Stephenson to Board of Directors
GlobeNewswire· 2025-03-14 04:15
BOSTON, March 13, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company”) today announced the appointment of Robert O. Stephenson to its Board of Directors. He will serve as an independent director and will be a member of the Audit Committee. Mr. Stephenson is the Chief Financial Officer of Omega Healthcare Investors, Inc., (NYSE: OHI) and has served in this capacity since August 2001. From 1996 to July 2001, Mr. Stephenson served as the Senior Vice President and Treasurer of In ...
Candel Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire· 2025-03-14 04:15
Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, localized prostate cancerRecently announced positive final data from randomized controlled phase 2a clinical trial of CAN-2409 in borderline resectable pancreatic ductal adenocarcinomaOn track to report biomarker and final overall survival data from open label phase 2a clinical trial per protocol analysis in non-small cell lung cancer (NSCLC) patients who received two ...